Addressing Challenges in Pharmaceutical Innovation through Strategic Collaboration and Digital Transformation
The pharmaceutical industry faces critical challenges, including focusing on profit-driven blockbuster drugs at the expense of [...]
J&J Seeks to Revolutionize Maternal Fetal Immunology with Nipocalimab
Johnson & Johnson is making strides in maternal-fetal immunology with its investigational monoclonal antibody, nipocalimab, aimed [...]
Podcast Q&A: EU HTA Joint Clinical Assessments
In this episode of tHEORetically Speaking, join Dr. Rosemary Jose, Dr. Sonja Kroep, and Nick Halfpenny from OPEN Health, Dr. Ansgar Hebborn from Roche, and James Ryan from AstraZeneca, who answer questions from a recent webinar on several policy aspects regarding the current challenges and implications of the EU Health Technology Assessment (HTA) regulation.
Global Growth and Challenges in the Respiratory Oxygen Delivery Devices Market (2023-2030)
The global Respiratory Oxygen Delivery Devices market is projected to grow from US$12.78 billion in 2023 [...]
Canon Medical and Olympus Partner to Enhance Endoscopic Ultrasonography and Expand Global Reach
Canon Medical Systems and Olympus have partnered to enhance the image quality of Endoscopic Ultrasonography (EUS) [...]
Telemedicine Trends and Challenges: Insights from IQVIA’s 2023 Remote Patient Care Study
The first article of a three-part series examines telemedicine’s role in healthcare, based on IQVIA’s “Remote [...]
Global Vascular Access Devices Market Expected to Grow to Nearly $15 Billion by 2030; Becton Dickinson and 3M Dominate the Market
The global vascular access device market reached a value of $12.5 billion in 2023 and is [...]
FDA Approves Interventional Systems’ Micromate: Next-Gen Needle-Based Intervention Robot for Medical Procedures in the US
Interventional Systems, an Australian robotics firm, has gained clearance from the US Food and Drug Administration [...]
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
This panel discusses several policy aspects regarding the current challenges and implications of the EU Health Technology Assessment (HTA) regulation.
Rising Biotech Stocks: Key Players to Monitor
10 Things You Need to Know: Biotech stocks continue to prosper long-term despite periodic fluctuations. In 2020, prominent biotech companies [...]
Medlinker’s AI Doctors Almost Match Human Physicians in Groundbreaking Live Test
Medlinker, a Chinese digital healthcare company, hosted a live comparison of its AI doctors, MedGPT, and human doctors in Chengdu, [...]
Medical Affairs Outsourcing Market Forecasted to Reach $3.28B by 2027
The global Medical Affairs Outsourcing Market is forecast to reach $3,287.12 million by 2027 from $1,415.00 million in 2019, growing [...]
ITIF Report: Global Drug Price Controls Restrict Pharmaceutical Research and Development
The Information Technology and Innovation Foundation (ITIF) study reports that drug price controls in non-US Organization for Economic Cooperation and [...]
Revolution in Women’s Health: First Over-The-Counter Contraceptive Coming to U.S. Shelves in 2024!
Perrigo's oral contraceptive, Opill, is now the first over-the-counter birth control pill in the United States. Opill has been around [...]
Sequoia Project and AHIMA Launch Health Data Usability Project
The Sequoia Project and the American Health Information Management Association (AHIMA) have partnered on the initiative "Data Usability Taking Root." [...]
BioGeneration Ventures Finalizes $167M Fund for Biotech Startups in Europe
What You Need To Know: Dutch venture capital firm BioGeneration Ventures (BGV) has secured €150 million ($167 million) for its [...]
Price Break: Cigna Welcomes Trio of Discounted Biosimilars to Preferred Drug Roster
What You Need to Know: Cigna Group's unit, Express Scripts, is adding three biosimilar versions of AbbVie's arthritis treatment Humira [...]
How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies
Literature reviews are an essential element in Real World Evidence (RWE) HEOR studies that impact patient care, policy development, and healthcare decision making.
Podcast Q&A: HEOR for Medical Technologies for the US Healthcare System
Expert, Deepak Sahu answers questions on developing HEOR studies for generating short- and long-term effectiveness data for medical technology.
Podcast Q&A: Discussing Health Technology Assessment Agencies
Join industry experts as they answer questions on what Health Technology Assessment (HTA) agencies do and the types of literature reviews they do.
Podcast Q&A: Streamlining Health Technology Assessments by Automating Literature Reviews
This podcast segment features the Q&A from DistillerSR's November 17, 2022 webinar and features a panel of experts, including Chris [...]
Streamlining Health Technology Assessments by Automating Literature Reviews
Experts provide a deep dive into what Health Technology Assessment (HTA) agencies do and the types of literature reviews they do.
Pandemic Windfall Upends Status Quo For Top-10 Best-Selling Drugs
Now that the books for 2021 are closed, In Vivo has crunched the numbers and can report on the best-selling [...]
OSE Immunotherapeutics Appoints Alexis Vandier as Chief Executive Officer
OSE Immunotherapeutics NANTES, France, July 13, 2022 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) is pleased to [...]
